At the end of the latest market close, Exelixis Inc. (EXEL) was valued at $16.88. In that particular session, Stock kicked-off at the price of $16.93 while reaching the peak value of $17.04 and lowest value recorded on the day was $16.72. The stock current value is $17.03.
Recently in News on June 28, 2021, Exelixis and Ipsen Announce Cabozantinib in Combination with an Immune Checkpoint Inhibitor Significantly Improved Progression-Free Survival in Phase 3 COSMIC-312 Pivotal Trial in Patients with Previously Untreated Advanced Liver Cancer. Exelixis, Inc. (NASDAQ: EXEL) and Ipsen (Euronext: IPN; ADR: IPSEY) today announced that COSMIC-312, the ongoing phase 3 pivotal trial evaluating cabozantinib (CABOMETYX®) in combination with atezolizumab versus sorafenib in patients with previously untreated advanced hepatocellular carcinoma (HCC), met one of the primary endpoints, demonstrating significant improvement in progression-free survival (PFS) at the planned primary analysis. A prespecified interim analysis for the second primary endpoint of overall survival (OS), conducted at the same time as the primary analysis for PFS, showed a trend favoring the combination of cabozantinib and atezolizumab but did not reach statistical significance. Based on the preliminary OS data, Exelixis anticipates that the probability of reaching statistical significance at the time of the final analysis is low. The trial will continue as planned to the final analysis of OS; results are anticipated in early 2022. You can read further details here
Exelixis Inc. had a pretty Dodgy run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $25.77 on 05/14/21, with the lowest value was $16.24 for the same time period, recorded on 07/19/21.
Exelixis Inc. (EXEL) full year performance was -31.30%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Exelixis Inc. shares are logging -37.73% during the 52-week period from high price, and 4.86% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $16.24 and $27.35.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 2127842 for the day, which was evidently lower, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Exelixis Inc. (EXEL) recorded performance in the market was -15.15%, having the revenues showcasing -30.97% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 5.53B, as it employees total of 773 workers.
The Analysts eye on Exelixis Inc. (EXEL)
During the last month, 12 analysts gave the Exelixis Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 2 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 1 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 22.35, with a change in the price was noted -4.63. In a similar fashion, Exelixis Inc. posted a movement of -21.38% for the period of last 100 days, recording 2,037,106 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for EXEL is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical rundown of Exelixis Inc. (EXEL)
Raw Stochastic average of Exelixis Inc. in the period of last 50 days is set at 8.29%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 10.85%. In the last 20 days, the company’s Stochastic %K was 6.82% and its Stochastic %D was recorded 3.93%.
Considering, the past performance of Exelixis Inc., multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be encouraging, given the fact the metric is recording -15.15%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -23.36%, alongside a downfall of -31.30% for the period of the last 12 months. The shares increased approximately by -2.63% in the 7-day charts and went up by -25.11% in the period of the last 30 days. Common stock shares were lifted by -30.97% during last recorded quarter.